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Abstract 
The objective was to investigate the effects of type 2 diabetes mellitus (T2DM) on tibial 
cortical and medullary cross-sectional areas (CSA) using magnetic resonance imaging. 
Sequential 1mm-thick slice images were acquired of the right leg from the tibial plateau to 
the talus in 8 individuals with T2DM and 9 age- and sex-matched (32 to 79 y) controls.  The 
CSA (cm2) was measured at 3 sites, 20%, 50% and 80% of tibial length, by a blinded 
analyzer.  At the 20% site, medullary CSA in T2DM was significantly greater than controls 
(mean ± SD: 5.9 ± 1.2 vs. 4.8 ± 0.7).  No differences were found at the 50% and 80% sites. 
These preliminary results indicate bone geometry is negatively affected by T2DM at the 
proximal tibia, due perhaps to decreased muscle tensions and accelerated aging.  Lower 
levels of physical activity, heavier body weights and diminished muscle strength may be 
other factors influencing T2DM bone geometry.  
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Chapter 1  
1 Brief Literature Review 
1.1 Bone 
Bone is a tissue of remarkable strength, found throughout the human body.  It has vital 
functions, including structural support, locomotion, protection of organs and calcium 
storage.  Bone is composed of mostly of type 1 collagen, a substance secreted by the 
osteoblast cells of bone.  The inherent strength of bone is derived from the hardening of 
collagen, completed by the mineral salts (e.g., hydroxyapatite, calcium carbonate) in the 
bone matrix (area surrounding the cells of the bones) (Bauer and Link, 2009).  Bone is 
porous, with many spaces between its hard, mineralized components.  The distribution 
and size of these spaces has led to two macroscopic classifications of bone: cortical (i.e., 
compact) and medullary (i.e., spongy, cancellous).  
Cortical bone contains fewer and smaller spaces, thus making the harder of the two bone 
types.  It is dense, strong and most resistant to compressive forces.  The external layer of 
all bones, and the outer layer of the shaft of long bones are made of cortical bone.  
Medullary bone consists of a spongy, latticework, or honeycomb-like trabeculae.  This 
architecture is less dense and lighter than that of cortical bone and centrally located, deep 
to the cortical bone.  
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Figure 1 Example of the components of a long bone (femur) 
As a highly metabolic and dynamic tissue, bone remodels to adapt to the external forces 
placed upon it.  For example, medullary bone remodels to increase thickness and number 
of trabeculae, and orient trabeculae axially relative to the stress placed upon the bone 
(Turner, 1998).  This remodeling is performed by osteoclast cells resorbing existing bone 
and osteoblast cells forming new bone (Novack and Teitelbaum, 2008; Romani et al., 
2002).  Imbalance in the remodeling process can lead to diseases of the bone, with 
negative implications for bone health, quality and strength (Novack and Teitelbaum, 
2008).  The most well-known and prevalent of these diseases is osteoporosis, in which 
osteoclast activity outpaces that of osteoblasts, leading to progressive bone degeneration 
(Bauer and Link, 2009; Novack and Teitelbaum, 2008).  Throughout this thesis, the 
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phrase “bone quality” will be used to refer to the mechanical competence of bone and its 
ability to resist fracture. 
1.1.1 Bone Quality and Geometry 
Bone quality is affected by multiple factors, including total bone mass, bone geometry 
(i.e., bone size & dimensions, gross structural geometry, and mass distribution), and the 
properties of the respective components of the bone (Burghardt et al., 2010; Hamilton et 
al., 2013; Honda et al., 2014).  Clinically, bone quality is essential as it is a predictor of 
fractures and necessary for independent living (Donnelly, 2011).  Fracture occurs when a 
bone is unable to withstand external forces resulting in failure of integrity (Garg et al., 
2012).  Multiple factors affect bone quality, including mechanical (e.g., load bearing, 
muscle contraction, geometry, mass and spatial distribution) and non-mechanical (e.g., 
hormones, diet, pharmaceutical, genetic) influences.  
Bone quality per se, is not measurable.  Rather, clinicians and researchers use surrogate 
measures to assess and infer bone quality.  Assessment of bone can be done at various 
anatomic levels ranging from macroscopic (whole bone) to microscopic (cellular and 
molecular levels), and using different in vivo and ex vivo measures.   
1.1.2 Assessment of Bone Quality  
When attempting to quantify bone quality, researchers and clinicians most frequently use 
dual-energy X-ray absorptiometry (DXA).  This 2-dimensional, macroscopic, in vivo 
assessment sends X-rays from two energies through the body and measures the 
attenuation of these X-rays.  From this, measurement of bone mineral content (grams) 
and bone mineral density (BMD, g/cm2) can be calculated (Bouxsein, 2008; Cummins et 
al., 2002; Donnelly, 2011).  DXA has many advantages, as it is cost-effective, non-
invasive, low radiation exposure, high precision and short measurement times.  It thus 
lends itself most readily to clinical screening and research.  The measure of BMD allows 
for clinical predictions of bone quality.  DXA is currently the gold standard imaging 
modality for prediction of fracture risk and low BMD is considered a risk factor for 
fracture (Bouxsein, 2008).  Furthermore, BMD is a surrogate measure of strength and the 
mechanical properties of bone (Bauer and Link, 2009; Beck, 2003; Bonnick, 2007; 
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Burghardt et al., 2010; Garg et al., 2012).  Despite the associations between BMD and 
fracture risk, BMD is not always indicative of the degree of bone strength, nor the risk of 
fracture (Beck, 2003).  One-half of post-menopausal women with an incident of low 
energy bone fracture (i.e., fall from standing) are above the World Health Organization 
BMD osteoporosis threshold (defined at ≥ 2.5 standard deviations below the average 
value for young, healthy women) (Bauer and Link, 2009; Bouxsein, 2008).  However, 
BMD is believed to contribute 70-75% of the variance in bone strength (Burghardt et al., 
2011).  Furthermore, despite having the same BMD, bones with different geometries can 
have very different strengths (Hamilton et al., 2013).  More sensitive measures of bone 
quality are required, which can assess and predict fracture risk with increased accuracy, 
and potentially determine the underlying causes of bone fragility.   
Recognizing the limitations of DXA, researchers and clinicians have turned to computer 
tomography (CT) to assess bone quality.  Quantitative CT (QCT) rotates X-rays around 
the body to create 3-dimensional (3D) images of bone geometry, measured as volumetric 
BMD (Donnelly, 2011).  This method allows for measurement of bone density separate 
from its size (unlike BMD), differentiation of the cortical and medullary components of 
bone, and assessment of more in depth bone quality measures, including geometric and 
microarchitectural (e.g., trabecular orientation and spacing, cortical porosity) features 
(Burghardt et al., 2011).  QCT has short scanning times and increased quality of 
assessment of geometry and volumetric bone density, but the limitations include patient 
exposure to ionizing radiation, increased cost and decreased availability (Donnelly, 
2011).  High-resolution peripheral QCT (HR-qCT) allows for extremely detailed, in vivo 
3D imaging of trabecular bone, but due to large doses of radiation to internal organs it is 
limited to distal extremity (the forearm and leg) sites (Burghardt et al., 2010).  This 
eliminates assessment of vertebral bodies and the hip (sites which are frequently 
fractured) (Burghardt et al., 2011).  Additionally, specialized scanners are required, 
decreasing accessibility, and longer scanning times increase motion artifact (Bouxsein, 
2008). 
Quantitative ultrasound is a useful modality in the assessment of bone in vivo.   With 
portable machines, no ionizing radiation and low cost, it was believed to be a promising 
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method of evaluating bone strength (Laugier, 2006).  Measurement of speed of sound 
(m/s) and broadband attenuation (dB/MHz) as the sound waves travel through the bone 
are used to estimate BMD.  However, the International Society of Clinical Densitometry 
only approves the calcaneous as a site for measurement of bone health (Krieg et al., 
2008).  Ultrasound has shown to be approximately equal to DXA for prediction of 
fracture risk (see Chin and Ima-Nirwana, 2013 for review).  Therefore with its low cost 
and portability, it is of increasing popularity in developing countries, and in countries 
where DXA is established, it is utilized almost exclusively in research settings (Laugier, 
2006).   
Use of magnetic resonance imaging (MRI) allows for generation of 3D images with no 
ionizing radiation and therefore without the associated risk of CT.  Strong magnetic fields 
can be coupled with radiofrequency pulse sequences to allow imaging of moving 
molecules within the body (typically from water and fat).  Thus, MRI is becoming a more 
popular mode of assessment of bone cross-sectional area (CSA) (Bouxsein, 2008), but is 
still limited by its increased expense and limited availability compared to DXA.  Bone 
imaging through MRI has been validated with comparison to cadaver CSA (Gomberg et 
al., 2005) and was found to highly correlate with CSA measures using  QCT (r2 = 0.98) 
(Hong et al., 2000).  Additionally, MRI has shown to have a high intra- and interobserver 
repeatability for all parameters (CV<0.8%) (Woodhead et al., 2001).   
MRI has a distinct advantage over DXA by allowing for simultaneous muscle 
assessment.  The largest stresses placed upon bone (excepting trauma) are forces due to 
muscle contraction (Frost, 1997).  For example, the abductor muscle group in the hip 
exerts forces several times larger than body weight in order to maintain a level pelvis in a 
one-legged stance (Burr, 1997).  Wolff’s Law, penned by Julius Wolff in 1892, states the 
mechanical load placed upon the bone adapts its remodeling process (Bauer and Link, 
2009; Frost, 2004).  It is well known and continually recognized that bone mass is linked 
to muscle strength; as muscle strength increases or decreases through changes in physical 
activity levels, bone mass follows (Burr, 1997).  Using MRI facilitates investigation of 
the relationship between muscle mass and bone quality (Frost, 1997; McNeil et al., 
2009).   
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1.1.3 Use of MRI to Assess Bone Geometry  
The body of literature using MRI to analyze bone quality is less well developed than that 
of CT or DXA.  Specifically, geometric and architectural features assessed by exploring 
areas and volumes of gross anatomical bone structure using MRI is a relatively new 
topic.  Because of this, there is understandably a lack of consistency with regards to 
methods on how to assess CSA with MRI.  Several studies have quantified bone CSA by 
analyzing the middle third of the femur (Duncan et al., 2002; Högler et al., 2003; Kato et 
al., 2014; Woodhead et al., 2001), but bone heterogeneity or alterations of specific 
features, such as cortical and medullary architecture assessed by CSA or volume, exists 
throughout the length of a limb bone.  Thus it is prudent, and beneficial, to compare 
multiple sites within the same bone to explore regional alterations in relation to potential 
bone remodeling due to disease or activity (Cole and van der Meulen, 2011; McNeil et 
al., 2009).  Additionally, averaging multiple MRI slices at the various main regions (e.g., 
proximal, middle and distal) is considered more representative of bone geometry than a 
single slice (Klein et al., 2002).  Populations which have been studied using MRI CSA 
include the elderly (Allen et al., 2012, 2011; Klein et al., 2002; McNeil et al., 2009), 
osteoporotic (Shen et al., 2013), elite athletes versus controls (Duncan et al., 2002; Honda 
et al., 2014; Kato et al., 2014; Nikander et al., 2009, 2007), peripubertal females (Högler 
et al., 2008, 2003; Maïmoun et al., 2013) and contra-lateral differences in one-sided 
dominant, competitive athletes (Ducher et al., 2011).  
Although there have been studies completed in the thigh and upper limb (see above), only 
two studies have assessed bone CSA using MRI in the leg.  McNeil et al. (2009) 
completed CSA measures in the leg in males, comparing young adults and older adults 
(61 – 91 years).  Although they found total CSA (tCSA) consistent at both proximal and 
distal sites of the tibia, the medullary CSA (mCSA) was greater and conversely, cortical 
CSA (cCSA) was lower in the elderly.  In a similar study conducted with young adult 
compared with older adult women (61 – 80 years), Allen et al. (2011) found tibial cortical 
volumes (calculated as: cCSA x slice thickness) were lower in the proximal section, but 
not in the distal section in the older women.   
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1.2 Diabetes 
Diabetes has become the fastest growing chronic disease, affecting nearly every country, 
including Canada (Diabetes in Canada, 2011; Shaw et al., 2010).  Canada has the third 
highest prevalence rate of diabetes (at just over 9%) of countries from Europe, North 
America and Oceania (Diabetes in Canada, 2011).  There are two types of diabetes.  
Type 1 diabetes mellitus affects only 5-10% of those with diabetes and is typically 
diagnosed in childhood or early adulthood.  It is the result of pancreatic dysfunction 
leading to insulin not being secreted by the beta cells; blood glucose levels are controlled 
with pharmacological insulin supplementation.  
Type 2 diabetes mellitus (T2DM) is the more prevalent version of diabetes; >90% of 
those with diabetes are classified as T2DM.  It stems from insulin insensitivity – the 
inability of tissue to use insulin for the uptake of blood glucose (Diabetes in Canada, 
2011).  With an increasingly passive lifestyle and its associated features, T2DM 
prevalence rates continue to rise across all age groups and races (Shaw et al., 2010; 
Sicree and Shaw, 2007).  Chronic hyperglycemia leads to a multitude of secondary 
complications, including cardiovascular disease, stroke, renal failure, neuropathy, 
retinopathy and changes in bone quality (Kannel and McGee, 1979).   These 
complications make diabetes a major cause of morbidity and mortality in North American 
and European countries (de Waard et al., 2014).    
1.2.1 T2DM and Bone 
Bone quality in the T2DM population has been extensively investigated.  There is an 
increased risk of low-trauma hip fracture (Gorman et al., 2011), estimated to be 1.4 times 
higher than otherwise similar and healthy controls (Schwartz and Sellmeyer, 2007).  
There are two main factors causing this increased fracture risk: increased falls and 
decreased bone quality (Vestergaard, 2007).  Many of the secondary complications 
associated with T2DM – retinopathies, neuropathies, muscular weakness, vestibular 
disorders, fainting due to hypoglycemia or orthostatic posture, and polypharmacy – 
increase the risk of falls (de Waard et al., 2014; Gower and Casazza, 2013; Vestergaard, 
2007).  However, when bone quality in those with T2DM has been explored using 
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imaging modalities, expected results have not been forthcoming.  Despite an increased 
fracture risk, DXA, the most frequently used modality for assessing bone health in 
T2DM, shows similar, if not increased BMD in the T2DM population (Gorman et al., 
2011; Schwartz and Sellmeyer, 2007; Vestergaard, 2007).  This creates a T2DM and 
BMD paradox; T2DM illustrated similar or increased BMD, yet decreased bone quality 
(i.e., higher risk of fracture).  This raises the concerns that 1) due to bone 
microarchitecture and structural geometry, T2DM bone may be more susceptible to 
fracture than bone of equal BMD in healthy controls (Hamilton et al., 2013; Schwartz and 
Sellmeyer, 2007) and 2) DXA is not a sufficiently sensitive method to assess fracture risk 
(Gorman et al., 2011).  Although frequently used in clinical practice, DXA has proven to 
be unhelpful in the T2DM population (Garg et al., 2012).  It does not explain the 
increased fracture risk in this population, and ultimately is not a measurement which can 
determine bone strength (Garg et al., 2012).  The more in depth and accurate HR-qCT has 
been used to further investigate whether changes in bone microarchitecture are 
responsible for the increased fragility in diabetic bone.  Cortical porosity, an important 
factor in bone quality (Sundh et al., 2015), has been found to be significantly higher in 
T2DM individuals compared to controls (Burghardt et al. 2010) and in T2DM with a 
history of a fragility fracture compared to T2DM without this history (Patsch et al., 
2013).  Petit et al. (2010) found an increase in trabecular density in the distal radius and 
tibia and Burghardt et al. (2010) noted a significantly increased trabecular thickness in 
the distal tibia.  These factors all indicate a redistribution of bone mass in T2DM, 
supporting the idea that diabetes reduces the ability of bone to respond to mechanical 
stimuli or alters the normal balance between bone accretion and resorption (Adami, 2009; 
Garg et al., 2012).  Ultrasound used to estimate BMD showed a decrease in speed of 
sound in T2DM and this result is more indicative of the increased risk of fracture, and 
thus some consider ultrasound a more useful tool for assessing bone health in those with 
diabetes (Tao et al., 2008).  Bone quality in those with diabetes assessed by MRI is 
limited, thus creating the purpose for this study. 
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1.2.2 T2DM & Bone CSA 
Studies assessing long bone CSA with MRI in T2DM population is limited.  Pritchard et 
al. (2012 & 2013) have completed two studies to assess radius bone quality in T2DM by 
means of MRI.  The first of these was completed in post-menopausal women and was 
designed to assess bone microarchitecture.  They did however also measure endosteal 
area (mCSA) at the distal aspect of the radius and found no difference between the 
T2DM and control groups (Pritchard et al., 2012).  The second study was a follow-up 
assessment of this same population, 2 years later, to longitudinally assess bone health.  
Again, mCSA at the distal radius was not significantly different between groups 
(Pritchard et al., 2013).   
There is a similar, but slightly better established, body of literature using QCT or HR-
qCT to assess bone CSA in T2DM.  In a population of postmenopausal women with 
T2DM, Burghardt et al. (2010) found no difference in tCSA, cCSA or mCSA in the distal 
aspects of either the radius or tibia compared to controls.  In males, Petit et al. (2010) 
found lower tCSA values for the tibia and radius in T2DM compared to controls after 
adjusting for age, race, clinic site, bone length and body weight.  When only the first 4 
variables were accounted for (excluding body weight), no difference was found between 
the two groups (Petit et al., 2010).  Melton et al. (2008) analyzed CSA of the distal 
forearm, comparing T2DM males and females with age- and sex-matched individuals, 
and adjusting for BMI.  At the radius, both the tCSA and mCSA were significantly 
smaller in T2DM than controls when analyzing both sexes as a combined group.  
However separately, only the tCSA in males was significantly smaller.  Although not a 
direct measure of CSA, cortical thickness (mm) was measured and not found to be 
significantly different (Melton et al., 2008).  Farr et al. (2014) also assessed cortical 
thickness and found it significantly lower in both the distal tibia and radius of T2DM 
females compared to age- and sex- matched controls.  This difference was no longer 
apparent after adjusting for BMI (Farr et al., 2014).  Thus, from the above studies, it is 
not clear whether individuals with T2DM exhibit differences in bone geometry, and if so, 
in what measures, compared to controls.   
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1.2.3 Indirect Effects on Bone Quality in T2DM 
The many complications of T2DM include both direct and indirect effects on bone 
quality.  Charcot neuroarthropathy is a complication of T2DM characterized by damage 
to bones and joints (typically in the ankle and foot), but as a secondary complication to 
neural dysfunction (i.e., diabetic neuropathy) (Low and Peh, 2015).  It typically leads to 
multiple fractures of the metatarsals and potential foot amputations.  The neurovascular 
theory of this cascade of events suggests denervation of the sympathetic nervous system 
leads to opening of the vasculature inside the bone, through reduced sympathetic tone 
(Mascarenhas and Jude, 2014).  This has two negative effects on bone strength.  First, 
through up-regulation of osteoclast cells and second, by quenching minerals 
(Mascarenhas and Jude, 2014; Varma, 2013).  Barwick et al. (2014) published a meta-
analysis assessing foot bone health in those with T2DM.  No significant difference in the 
calcaneus bone was found between diabetics with neuropathy and diabetics without 
neuropathy through assessment with ultrasound, X-ray and DXA (Barwick et al., 2014).  
 
 
11 
 
Chapter 2  
2 Introduction 
Diabetes is a growing concern in the Canadian health care system.  Canada has the third 
highest prevalence rate of countries in North America, Europe and Oceania, with 1 in 11 
adults diagnosed with the disease (Diabetes in Canada, 2011).  Of individuals with 
diabetes, 90-95% have type 2 diabetes mellitus (T2DM) (i.e., non-insulin dependent 
diabetes mellitus) (Diabetes in Canada, 2011).  T2DM is known to lead to a multitude of 
secondary complications, including retinopathies, neuropathies, cardiovascular disease 
and alterations in bone quality.  Bone quality in T2DM has been studied extensively with 
dual-energy x-ray absorptiometry, the current gold standard for assessment of bone 
fracture-risk and osteoporosis.  In the T2DM population, a higher fracture risk and 
incidence rate is noted, but these individuals also have a higher bone mineral density 
(BMD) than their non-T2DM counterparts (Gorman et al., 2011; Schwartz and 
Sellmeyer, 2007; Vestergaard, 2007).  This has created a T2DM and BMD paradox.  The 
increased fracture risk is partly explained by increased risk and frequency of falls, but 
after eliminating these factors T2DM bone is still at higher risk of fracture than a non-
T2DM bone of equal BMD (Schwartz and Sellmeyer, 2007).   
The relationship between T2DM and bone quality has been explored to lesser extents 
using more in-depth and detailed imaging modalities, including quantitative computed 
tomography (QCT) and magnetic resonance imaging (MRI).  Long bone cross-sectional 
area (CSA) has been assessed through QCT, with no consensus regarding whether 
changes are present in T2DM compared to controls.  Burghardt et al. (2010) found no 
difference in total (tCSA), cortical (cCSA) or medullary (mCSA) CSAs of the distal 
radius or tibia in postmenopausal females compared between individuals with T2DM and 
those without.  In older males with T2DM, Petit et al. (2010) found a lower tCSA in the 
radius and tibia compared to controls, after adjusting for body weight.  Melton et al. 
(2008) used a sample of both males and females, assessing distal forearm CSA.  When 
both sexes were combined, a significant decrease in tCSA and mCSA was detected; when 
assessing the sexes separately only tCSA in males was significantly decreased compared 
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to controls.  Cortical bone was measured as thickness (mm) (rather than CSA) and no 
difference was found between the two groups by Melton et al. (2008) nor Farr et al. 
(2014).  Finally, Pritchard et al. (2013 & 2012) completed a longitudinal study analyzing 
radius bone health in postmenopausal T2DM women via MRI.  At both the first time 
point and the follow up visit 2 years later, no differences were found in mCSA (the only 
CSA measured) at the most distal aspect of the radius.  Thus from these relatively few 
studies of mixed designs, it is unclear why bone quality is lessened in those with diabetes, 
and whether these negative alterations can be assessed via bone CSA measurements.  
Some of the limitations of these previous studies include measurement of CSA at only 
one point throughout the length of the bone, and assessment of only one of the three 
potential CSA measures (total, cortical or medullary).  The current study is being 
conducted to determine whether the lesser bone quality observed in those with T2DM 
will be reflected through tibial CSA and volumetric measures.  Previous studies have not 
assessed the three CSA measures at three different points throughout the length of the 
tibia, as well as cortical and medullary volumes.  This comprehensive set of measures 
will allow for a more thorough investigation of bone geometry to determine differences 
which may occur in the T2DM individuals compared to controls.  MRI is the imaging 
modality chosen for this study due to its relative patient safety, accurate measurements 
and novelty in the diabetic population, as only one other study has assessed T2DM long 
bone CSA with MRI (Pritchard et al., 2013, 2012).  The ankle shows a higher relative 
risk of fracture than other sites in the body (Schwartz et al., 2001) and thus the tibia was 
selected as an important bone in the ankle joint.  It has only been studied in the T2DM 
population a limited number of times with CSA measurements (Burghardt et al., 2010; 
Petit et al., 2010), and not with MRI.  Based on the results of similar CSA assessment 
studies in individuals with T2DM (Melton et al., 2008; Petit et al., 2010), it was 
hypothesized that in the tibiae of a group of participants with T2DM there will be a lower 
tCSA compared to an age- and sex-matched control group.  This smaller tCSA will be 
explained by a matching smaller mCSA and no change in cCSA.      
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Chapter 3  
3 Methods 
3.1 Participants 
Individuals were recruited for a larger study focusing on the neuromuscular properties of 
individuals diagnosed with a diabetic neuropathy.  Individuals were included based on 
the presence of T2DM, with clinical and electrophysiologoical features confirming the 
diagnosis of diabetic neuropathy.  Clinical neurological and electrophysiological testing 
eliminated other possible conditions.  The diabetic neuropathy group included 8 
individuals (32-79 years; 3 females); the control group included 9 age- and sex-matched 
individuals (4 females).  All were recruited from the community and screened for 
exclusion criteria.  The local university’s Research Ethics Board approved the study and 
all individuals gave informed oral and written consent.  
3.2 Imaging 
Magnetic resonance images of the leg were acquired in all individuals.  Participants were 
supine and entered the magnet feet first.  Feet and knees were strapped together with 
inelastic Velcro straps to minimize potential movement of the lower limb.  Both legs 
were imaged, including the knee and ankle joints using serial axial plane imaging in a 
3.0-T magnet (Verio MRI, Siemens, Erlangen, Germany).  The following parameters 
were used for proton density acquisition: 9.57 ms repetition time (TR), 2.46 ms echo time 
(TE), 240 x 320 mm field of view, and 1 mm slice thickness. 
3.3 Image Analysis 
 CSA analysis of the leg was completed off-line, using stored images (see Figure 2), by 
one trained and blinded analyzer using OsiriX image processing software (version 4.0, 
Geneva, Switzerland).  tCSA of the tibia was measured beginning at the first slide distal 
to the tibial articular surface of the knee joint and continued until the articular surface for 
the talus.  The closed polygon tool was used to create a region of interest (ROI), isolating 
the tibia from the remainder of the leg.  This was repeated every fifth slice; OsiriX 
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automatically interpolated an ROI for the missing intermediate slides.  Every slide was 
visually inspected by the analyzer and any errors produced through automatic ROI 
generation were manually corrected.  All pixels outside the ROI were set to white; pixels 
within the ROI were differentiated by density to determine cortical bone from the 
medullary area.  The software calculated the respective CSA of the entire ROI (tCSA), 
cCSA and mCSA regions.  This method has been shown to have a high intra- and 
interrater reliabilities (Berger et al., 2012).  Proximal, middle and distal CSAs were 
calculated by averaging two adjacent slices at 20% (proximal site), 50% (middle site), 
and 80% (distal site) of tibial length, measured from tibial plateau to talus.  Volume of 
the entire tibia was calculated by OsiriX, using the respective CSA slices and multiplying 
by the slice thickness, creating total volume (TV), cortical volume (CV) and medullary 
volume (MV) (measured in cm3).  CV and MV were analyzed as a percentage of TV.   
3.4 Statistical Analysis 
Means were compared between the control and DN groups using an independent t-test, 
using SPSS (Version 22, IBM, Chicago, IL).  Values in tables and figures are expressed 
as mean ± standard deviation; significance was given if p ≤ 0.05. 
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Figure 2 Control and T2DM tibiae at proximal, middle and distal sites   
The control individual on the left is a 65 year-old male; the T2DM individual on the right 
is a 79 year-old male with T2DM for 35 years (22 years of diabetic neuropathy) showing 
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extreme changes in bone geometry.  T2DM, type 2 diabetes mellitus; ROI, region of 
interest. 
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Chapter 4  
4 Results 
4.1 Participant Characteristics 
The diabetic sample (n=8) of participants had an average age of 60.4 ± 15.0 years, height 
of 169.0 ± 7.4 cm, weight of 83.7 ± 8.2 kg and body mass index (BMI) of 29.4 ± 2.8 
kg/m2.  The average duration of T2DM was 14.4 ± 10.2 years and the average duration of 
diabetic neuropathy was 8.8 ± 6.2 years.  The control group (n=9) had an average age of 
57.3 ± 19.0 years, height of 174.5 ± 8.0 cm, weight of 77.2 ± 9.0 kg and BMI of 25.3 ± 
1.4 kg/m2.  Only BMI was statistically different between the two groups, being greater in 
the T2DM sample.  Participant characteristics are shown in Table 1. 
4.2 Tibial CSA & Volume   
The tCSA, cCSA and mCSA (measured in cm2) were analyzed at each respective leg 
length site and compared between the control and T2DM group.  At the proximal site, 
mCSA was significantly greater (p<0.05) in the T2DM group than controls (5.9 ± 1.2 vs. 
4.8 ± 0.7).  However, as a percent of tCSA, the T2DM group did not have significantly 
more mCSA.  No other significant results were found at any site of the tibia.  
As a percentage of TV, neither CV nor MV were significantly different between the 
control and T2DM groups.  Table 2 includes all values, including CSA, expressed as 
mean ± SD.   
The above CSA and volume results were correlated to duration of T2DM and duration of 
diabetic neuropathy.  No significant correlations were found. 
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Table 1 Participant characteristics 
  Age (y) Height 
(cm) 
Weight 
(kg) 
BMI 
(kg/m2) 
Length of 
T2DM (y) 
Length of 
DN (y) 
Control (n=9, 
5 males) 
57.3 ± 19.0 174.5 ± 8.0 77.2  ± 9.0 25.3 ± 1.4        -----      ----- 
T2DM (n=8, 
5 males) 
60.4 ± 15.0 169.0 ± 7.4 83.7  ± 8.2 29.4  ± 2.8* 14.4  ± 10.2 8.8 ± 6.2 
Values are mean ± SD. BMI, body mass index; T2DM, type 2 diabetes mellitus; DN, 
diabetic neuropathy.  
*Significant difference between groups (p ≤0.05)  
Table 2 Geometry of the tibia 
 Control T2DM 
Tibia Proximal Site   
     tCSA (cm2) 7.7± 1.0 8.9 ± 1.5 
     cCSA (cm2) 2.8 ± 0.6 2.8 ± 0.6 
     mCSA (cm2) 4.8 ± 0.7 5.9 ± 1.2* 
     Relative cortical area (%) 37.0 ± 5.0 32.3 ± 5.9 
     Relative medullary area (%) 63.0  ± 5.0 66.5 ± 5.2 
Tibia Middle Site   
     tCSA (cm2) 4.3 ± 0.8 3.1 ± 0.8 
     cCSA (cm2) 3.1 ± 0.8 3.2 ± 0.6 
     mCSA (cm2) 1.2 ± 0.4 1.3 ± 0.4 
     Relative cortical area (%) 72.8 ± 8.9 70.7 ± 8.1 
     Relative medullary area (%) 27.3 ± 8.9 29.4 ± 8.1 
Tibia Distal Site   
     tCSA (cm2) 4.3 ± 1.2 4.0 ± 0.6 
     cCSA (cm2) 1.9 ± 0.3 2.1 ± 0.5 
     mCSA (cm2) 2.4 ± 0.9 2.0 ± 0.5 
     Relative cortical area (%) 45.9 ± 6.6 51.1 ± 7.5 
     Relative medullary area (%) 54.1 ± 7.5 48.5 ± 9.8 
Tibial Volume   
     Relative cortical volume (%) 36.1 ± 8.4 31.4 ± 5.6 
     Relative medullary volume (%) 63.9 ± 8.4 68.6 ± 5.6 
Values are mean ± SD.  T2DM, type 2 diabetes mellitus; tCSA, total cross-sectional area; 
cCSA, cortical cross-sectional area; mCSA, medullary cross-sectional area. 
*Significant differences between groups (p≤0.05) 
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Figure 3 T2DM respective CSAs as percent of control CSAs at proximal site 
Values are mean ± SD.  CSA, cross-sectional area; T2DM, type 2 diabetes mellitus. 
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Chapter 5  
5 Discussion 
5.1 General Discussion 
This study was conducted to determine whether bone structural geometry differed 
between individuals with T2DM and sex- and age-matched controls through assessment 
with MRI.  Except for a significantly larger mCSA at the proximal tibia in T2DM 
compared with the control group, there were no other differences detected in the various 
bone parameters measured.  This result is not in agreement with the hypothesis, in which 
it was expected that the tCSA and mCSA would be lower in the T2DM group compared 
to controls.  
Although the sample size was not large, the groups were well matched, with the average 
control age of 57.3 ± 19.0 years and T2DM age of 60.4 ± 15.0 years with an average 
duration of T2DM of 14.4 ± 10.2 years.  The T2DM tended to have a larger body mass 
and shorter stature, thus leading to a significantly larger BMI (29.4 ± 2.8 vs. 25.3 ± 1.4 
kg/m2).  Despite this difference in BMI, overall bone CSA was not significantly different 
between these groups, and only one of the submeasures (proximal mCSA) was 
significantly different.   
Although larger BMI is positively correlated to higher BMD, there are still a significant 
number of fractures in the obese population (Ong et al., 2014).  A larger BMI places 
more mechanical load upon bones, stimulating bone remodeling, but excess adipose 
tissue negatively affects bone metabolism (Gower and Casazza, 2013).  In the present 
study, the larger BMI of T2DM group was reflected in a greater amount of non-muscle 
tissue of the leg muscles (see Figure 2).  This difference was quantified in a companion 
study by (Allen et al., 2014).  Thus, the amount of viable muscle tissue in the leg of the 
T2DM group was not larger despite heavier body weight.  It appears the effects of excess 
adipose tissue at a cellular level offset any stimulation for bone remodeling at a gross 
anatomical level, due to heavier body mass.  Furthermore, it is unknown how the 
interactions in quality or relative quantities of these tissues are affected by physical 
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activity in this population.  Muscle pull and weight bearing are the largest drivers of bone 
remodeling (Burr, 1997).  Two of the subjects used mobility aids, one was wheelchair 
bound and, in general, individuals with T2DM do not exercise regularly (Krug et al., 
1991).  Therefore it is challenging to distinguish changes in bone health due to physical 
inactivity or diabetes.  Park (2006) assessed muscle quality (muscle strength per unit 
regional muscle mass) in diabetics compared to controls, and found it was significantly 
decreased in diabetics, despite having an increase in actual muscle mass.  This may mean 
that those with T2DM are placing less load upon their bones due to muscular contraction 
than controls, and therefore may help to explain the significantly larger mCSA in the 
proximal section of the tibia.  Many muscles groups of the thigh and leg have attachments 
on the proximal tibia; reduced muscle actions on the bone may be causing a decrease in 
bone quality in this region.  This may be related to what occurs with normal adult aging 
in long bones in which there is endosteal resorption (i.e., osteoclasts resorbing cortical 
bone by working superficially, or outwards, from the deep surface of cortical bone, 
bordering the medullary cavity) (Seeman, 2001).  This decreases the cCSA and increases 
the mCSA, with no change in tCSA (Frost, 1997).  The larger mCSA observed at the 
proximal site in the T2DM participants may be indicative of early stages of bone aging, 
accelerated in those with T2DM.  This can be paralleled to the research by Andreassen et 
al., (2009) documenting accelerating muscle atrophy (i.e., aging) in the leg of individuals 
with diabetic neuropathy.  Further studies are needed to determine the relationship 
between aging and bone in the T2DM population.  Indeed, correlations between bone 
CSA, and length of T2DM and diabetic neuropathy were not significant in this relatively 
small sample. 
Burghardt et al. (2010) assessed cross-sectional geometry using HR-qCT and found no 
differences between T2DM and controls in tCSA, cCSA or mCSA at the most distal 
aspects of the radius or tibia.  In this study, scans more proximal than Burghardt et al. 
(2010) were analyzed, including mid-diaphysis, for a better representation of cortical 
bone, which might be important when assessing a weight bearing bone.  Petit et al. (2010) 
found a decrease in tCSA in T2DM men compared to controls at both 4% and 66% of 
tibial length (measured from the distal end) with peripheral QCT, but only after 
controlling for body weight.  The lower tCSA helps explain the higher BMD measured 
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with DXA, as BMD is a measurement of bone mineral content per area (cm2).  Decreases 
in the area of a bone with no changes in mineral content will increase BMD (Beck, 2003; 
Petit et al., 2010; Strotmeyer et al., 2004).  Noting the changes reported by Petit et al. 
(2010), the results of this study were normalized to body weight to explore whether tCSA 
might be smaller in T2DM compared to controls once body weight was controlled, but no 
significant differences were found between the T2DM and control participants.  
None of the participants in the current study had neuropathic issues severe enough to lead 
to Charcot neuroarthropathy, yet these underlying issues related to bone integrity as a 
consequence of diabetic neuropathy cannot be ignored.  In a review published by 
Barwick et al. (2014) no difference was found in calcaneal bone health between diabetics 
with and without neuropathy through assessment with ultrasound, X-ray and DXA.  This 
is of interest here, as it implies the inclusion criteria of diabetic neuropathy does not limit 
the results of the present study to those with diabetic neuropathy.  Neuropathy affects 
individuals in a distal to proximal fashion (Barwick et al., 2014).  As such, the tibia may 
only display changes due to neuropathy after an extended length of time with the disease.  
With this in mind, duration of diabetic neuropathy was correlated with the CSA measures 
and percent MV and CV, but no statistically significant relationships were found.  For a 
variety of potential reasons, including a more proximal site in the body and a larger bone, 
the tibia appears to not be affected by diabetic neuropathy, at least overtly using the MRI 
CSA assessment method and with the current sample size.   
From the results of the present study, increased fracture risk in T2DM may not be evident 
in overall geometry.  Nevertheless bone quality may be affected by poorer structural 
integrity of the bone tissue itself that is not reflected in gross bone architecture.  For 
example, greater cortical porosity has been found in T2DM who have suffered a fragility 
fracture compared to T2DM without a fragility fracture history (Patsch et al., 2013).  
Cortical porosity was not increased in T2DM without a fragility fracture history 
compared to controls, thus it cannot be assumed that increased cortical porosity is 
characteristic of T2DM (Patsch et al., 2013).  Trabecular spacing has also been found to 
be greater in T2DM than controls (Pritchard et al., 2012).  These microarchitectural 
23 
 
factors, which are not apparent with gross imaging, will affect the ability of bone to 
withstand forces, and thus its susceptibility to fracture. 
Furthermore, hormonal, pharmaceutical or nutritional factors are also known to affect 
bone quality.  For example, the thiazolidinedione (TZD) class of antidiabetic drug and 
chronic hyperglycermia levels both stimulate differentiation of mesenchymal cells into 
adipocytes at the expense of osteoblasts (Bazelier et al., 2012).  Conversely, metformin, 
an insulin sensitizer anti-diabetic drug not in the TZD class, works in the opposite 
direction, decreasing risk of bone fracture through promotion of mesenchymal stem cells 
into osteoblasts rather than adipocytes (Yan and Li, 2013).  Chronic hyperglycemia also 
leads to increased calcium excretion by the kidneys and decrease calcium absorption in 
the gut (McNair et al., 1979) and decreased renal function, a typical complication of 
T2DM, also alters bone structure (Jokihaara et al., 2006).  These factors have not been 
measured in the present study but may impact bone health before overall geometric 
changes are detectable. 
5.2 Summary and Conclusion 
In conclusion, the current study found changes in T2DM bone quality compared to 
controls, assessed through CSA and volume in the tibia, only in the proximal mCSA.  
The greater mCSA in the T2DM compared with controls may be caused by a decrease in 
muscle pull due to decreased muscle quality in T2DM.  The proximal tibia is the 
attachment point for the major muscles of the thigh and leg, and thus decreases in muscle 
quality will have the largest effect at this site.  Additionally, a larger mCSA is an 
alteration typically seen in adult long bone aging and the results from this study results 
may indicate bone aging is accelerated in those with T2DM.  Furthermore, negative 
alterations in bone microstructure that are not apparent with measures of gross geometry 
may affect bone quality and ultimately help explain the increased fracture risk in those 
with T2DM. 
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5.3 Limitations & Future Directions 
There are several limitations to this study.  These include a small sample size and not 
controlling for BMI and physical activity levels between the two groups.  Increasing 
sample size to analyze the sexes both individually and separately (and controlling for 
menopausal status of female participants) would also help eliminate confounding factors.  
MRI assessment of two diabetic groups – one with a known fragility fracture history and 
one without this history – also may help elucidate changes in bone geometry.  Similar to 
cortical porosity, changes in bone geometry might only be evident in individuals with a 
history of fragility fractures.  It would also be interesting to analyze tibial CSA in 
comparison to other long bones, both weight bearing (e.g., femur) and non-weight 
bearing (e.g., fibula, radius), to determine whether differences occur between bones of 
the appendicular skeleton.  Finally, using more detailed, in vivo imaging modalities, such 
as HR-qCT, to assess both CSA and microarchitectural features may help determine the 
degree of relation between these variables and their combined influence on bone quality 
in T2DM.  
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